中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共2条，第1-2条 帮助

已选(0)清除 条数/页：   排序方式：
Tislelizumab Plus GemOx in Patients with Relapsed/Refractory Classic Hodgkin Lymphoma: A Single-Arm, Multi-Center Phase II Trial 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Liu, Hailing;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli;  Wu, Wei;  Zhang, Xiaoyan;  Wang, Li;  Xu, Wei;  Zhu, Huayuan;  Li, Jianyong;  Fan, Lei
收藏  |  浏览/下载：34/0  |  提交时间：2022/12/23
The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Shi, Xiao;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli;  Liu, Hailing;  Wu, Wei;  Zhang, Xiaoyan;  Wang, Li;  Xu, Wei;  Zhu, Huayuan;  Li, Jianyong;  Fan, Lei
收藏  |  浏览/下载：50/0  |  提交时间：2022/12/23